📊 MRNA Forecast Outcome - Core Portfolio Distribution Model
Asset: Moderna Inc. (MRNA)
Forecast Initiated: May 2024 (2nd week)
Price at Forecast Initiation: $25.00 per share
Chart Basis: Daily Timeframe
Model: Core Portfolio Distribution Cycle
🔍 Summary of Results:
In May 2024, Moderna (MRNA) was forecasted using the Core Portfolio Distribution Model while trading near $25.00. The model identified a potential Stage 1 Accumulation Phase, projecting a support level validation as the prerequisite for bullish entry.
✅ Support Level Confirmed: The support confirmation zone successfully held, validating the first accumulation zone setup.
✅ Drop Level Completed: Price retested the lower region as predicted, reaching the projected drop zone ($27.23), then reversed as modelled.
✅ Trade 1 Executed: The model’s first entry-level led to a breakout to the $34.55 area, aligning with Level 2 targets ($34.71–$36.35).
🔜 Heading to Distribution: Price is now entering Stage 3: Distribution Phase, with the second trade opportunity forming between projected (C)-(E) wave structure.
🎯 Next Key Levels:
Trade 2 Target Zone: ~$37.15 to $44.61
Support Retest Zone for 2nd Entry: Expected pullback to $30 - $31 range before final distribution push.
🧠 Model Takeaway:
This outcome reflects another successful execution of the Core Portfolio Distribution Cycle model. Forecasted over 2 months in advance with precision entry, breakout validation, and level-to-level progression all confirming high-probability zones with real-time structure adaptation.
Disclaimer: The following forecast is derived from a proprietary, hand-crafted mathematical model developed independently over several years. It does not rely on traditional indicators, technical patterns, or third-party frameworks such as Elliott Wave Theory.
This model calculates price action based on distribution phases, economic timing cycles, and natural market imbalances.
I’ll continue publishing live cycle forecasts across key assets - built with institutional discipline and retail accessibility.
#(MRNA) #MarketForecast #DistributionCycle #TradingModel #QuantitativeAnalysis #InstitutionalTrading #Stage3Distribution #AssetManagement #TradingStrategy #SymmetryInMarkets #ForecastAccuracy
Asset: Moderna Inc. (MRNA)
Forecast Initiated: May 2024 (2nd week)
Price at Forecast Initiation: $25.00 per share
Chart Basis: Daily Timeframe
Model: Core Portfolio Distribution Cycle
🔍 Summary of Results:
In May 2024, Moderna (MRNA) was forecasted using the Core Portfolio Distribution Model while trading near $25.00. The model identified a potential Stage 1 Accumulation Phase, projecting a support level validation as the prerequisite for bullish entry.
✅ Support Level Confirmed: The support confirmation zone successfully held, validating the first accumulation zone setup.
✅ Drop Level Completed: Price retested the lower region as predicted, reaching the projected drop zone ($27.23), then reversed as modelled.
✅ Trade 1 Executed: The model’s first entry-level led to a breakout to the $34.55 area, aligning with Level 2 targets ($34.71–$36.35).
🔜 Heading to Distribution: Price is now entering Stage 3: Distribution Phase, with the second trade opportunity forming between projected (C)-(E) wave structure.
🎯 Next Key Levels:
Trade 2 Target Zone: ~$37.15 to $44.61
Support Retest Zone for 2nd Entry: Expected pullback to $30 - $31 range before final distribution push.
🧠 Model Takeaway:
This outcome reflects another successful execution of the Core Portfolio Distribution Cycle model. Forecasted over 2 months in advance with precision entry, breakout validation, and level-to-level progression all confirming high-probability zones with real-time structure adaptation.
Disclaimer: The following forecast is derived from a proprietary, hand-crafted mathematical model developed independently over several years. It does not rely on traditional indicators, technical patterns, or third-party frameworks such as Elliott Wave Theory.
This model calculates price action based on distribution phases, economic timing cycles, and natural market imbalances.
I’ll continue publishing live cycle forecasts across key assets - built with institutional discipline and retail accessibility.
#(MRNA) #MarketForecast #DistributionCycle #TradingModel #QuantitativeAnalysis #InstitutionalTrading #Stage3Distribution #AssetManagement #TradingStrategy #SymmetryInMarkets #ForecastAccuracy
Institutional Note:
For institutional review, independent verification, or strategic collaboration:
[email protected]
For institutional review, independent verification, or strategic collaboration:
[email protected]
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Institutional Note:
For institutional review, independent verification, or strategic collaboration:
[email protected]
For institutional review, independent verification, or strategic collaboration:
[email protected]
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.